
Sign up to save your podcasts
Or
Dr. Iyad Alnahhas interviews Dr. Craig Horbinski about his and his team's recent manuscript entitled "The novel DNA cross-linking agent KL-50 is active against patient-derived models of new and recurrent post-temozolomide mismatch repair-deficient glioblastoma", published online in Neuro-Oncology in December 2024.
4.8
1212 ratings
Dr. Iyad Alnahhas interviews Dr. Craig Horbinski about his and his team's recent manuscript entitled "The novel DNA cross-linking agent KL-50 is active against patient-derived models of new and recurrent post-temozolomide mismatch repair-deficient glioblastoma", published online in Neuro-Oncology in December 2024.
38,689 Listeners
90,949 Listeners
288 Listeners
12,103 Listeners
2,321 Listeners
69,085 Listeners
165,721 Listeners
59,349 Listeners
317 Listeners
12,348 Listeners
28,494 Listeners
15,335 Listeners
8,874 Listeners
9,964 Listeners
7,419 Listeners